Web conference on Merrimack announcement

Ipsen announced on January 9, 2017 that it has entered into a definitive agreement to acquire global oncology assets from Merrimack Pharmaceuticals, including its key marketed product ONIVYDE®.

 

Conference call & web conference:  

  • Date: 9 January, 2017 
  • Time: 2:30pm CET/ 8:30am EST 

 

Replay available for seven days. Click here or dial:

  • France and continental Europe +33 (0)1 7099 3529 
  • UK +44 (0)20 7031 4064 
  • United States +1 954 334 0342 
  • Conference ID: 961094

 

Click here to access the press release.

Last update 12/01/2017